Delivering efficient, technology-driven patient safety solutions

This infosheet explores Fortrea's pharmacovigilance and patient safety solutions.

Serving as an extended safety partner for an emerging biotech's vaccine studies

This case study outlines how Fortrea served as an extended safety partner for an emerging biotech's vaccine studies.

Exceeding challenging milestones through teamwork and innovation

This case study delves into meeting and exceeding trial milestones on very short timelines.

Elevate your neuromuscular clinical studies with Fortrea’s specialized expertise and comprehensive support

Sharing our best patient-centric practices from extensive experience in Alzheimer’s Disease.

At Fortrea, we’re committed to advancing research in Alzheimer’s Disease (AD) and other dementias. Learn about our best practices and recommendations developed from years of experience advancing these complex studies.

Going beyond the boundaries of a clinical trial: how Dr. Barbara Gillespie is working to address disparities in kidney disease

As part of her commitment to advancing nephrology research, Dr. Gillespie is helping build trust in clinical trials within patient groups. H

Unleashing the power of data sharing to transform the drug development landscape for kidney diseases

In 2016, Barbara Gillespie, MD, FASN, Vice President and Therapeutic Head of Nephrology at Fortrea, joined a workgroup with the Kidney Health Initiative (KHI) and U.S. FDA. T

Implementing a novel approach for recruiting a seasonal pediatric vaccine mega-trial

This case study demonstrates how Fortrea developed a novel approach to successfully delivery a large, industry-sponsored Phase III clinical trial to prevent hospitalization of infants due to a seasonal and dangerous illness.

Digital transformation in market access

Digital transformation is a grand phase—it can cover technological innovation, data and processes and even global organizational change, yet it doesn't have to be a daunting prospect left to those loooknig for systemic change at a company level.